Yokogawa Electric Corporation

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
Yokogawa has over 100 years of expertise in systems engineering and automation. Through the newly formed Life Innovation Business Unit, cutting-edge technologies for bioprocess and cellular imaging are available. Yokogawa’s fully-automated bioreactor system (BR1000) eliminates the need for off-line assays, while enhancing viable cell counts and boosting performance in mammalian cell culture for production of biologics, such as monoclonal antibodies. By combining fully-integrated near-infrared (NIR) and electrical impedance sensors for continuous data acquisition, with proprietary predictive control (automation) algorithms, the BR1000 bioreactor offers superior performance. Furthermore, Yokogawa also has confocal microscopic systems that employ unique technologies for high-speed live cell imaging and analytics. Benchtop models through high-throughput complete live-cell screening systems are available for applications in basic research to drug-discovery.
Tokyo Stock Exchange
Company Type:
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
Process Control & Automation Equipment for biopharm manufacturing
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Global Market Development
Yokogawa Electric Corporation